Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cross-linked sodium hyaluronate gel with lidocaine
- Development stage
- Unknown
- Lead developer
- Sinclair
- Administration
- Intradermal, Subcutaneous
01
Overview
Cross-linked sodium hyaluronate gel with lidocaine is a series of injectable dermal fillers developed by Haohai Healthcare Holdings for aesthetic soft tissue augmentation. The product consists of a stabilized, cross-linked hyaluronic acid (HA) gel, which provides structural support and volume to the skin to correct wrinkles, folds, and volume loss. The cross-linking process enhances the durability of the HA within the tissue by resisting enzymatic degradation by hyaluronidase. The inclusion of lidocaine, a local anesthetic, is intended to minimize pain during the injection process, improving patient comfort. Haohai's pipeline includes multiple generations of this formulation, with the first version already approved and subsequent iterations in clinical development.
- Brand names
- JanlaneHyalutightMatrifill
- Other names
- cross-linked sodium hyaluronate gel with lidocainecross-linked hyaluronic acid gel with lidocaine
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on cross-linked sodium hyaluronate gel with lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cross-linked sodium hyaluronate gel with lidocaine.